Income Statement (TTM)
Rainmed Medical Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 81 | 85 | 89 | 86 | 84 | 83 | 82 | 78 | 73 | 61 | 50 | 45 | 40 | 32 | 23 |
Change (%) | 4.81 | 4.59 | -3.04 | -3.13 | -0.91 | -0.92 | -5.40 | -5.71 | -16.05 | -19.12 | -9.95 | -11.04 | -20.67 | -26.06 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 12 | 13 | 13 | 14 | 14 | 17 | 20 | 22 | 25 | 22 | 20 | 18 | 16 | 14 | 13 |
Change (%) | 5.42 | 5.14 | 1.09 | 1.08 | 21.96 | 18.01 | 12.19 | 10.86 | -9.95 | -11.05 | -9.62 | -10.64 | -9.17 | -10.10 | |
% of Revenue | 14.98 | 15.07 | 15.15 | 15.80 | 16.48 | 20.29 | 24.16 | 28.65 | 33.69 | 36.14 | 39.74 | 39.89 | 40.07 | 45.88 | 55.78 |
Gross Operating Profit | 69 | 72 | 76 | 73 | 70 | 66 | 62 | 55 | 49 | 39 | 30 | 27 | 24 | 17 | 10 |
Change (%) | 4.71 | 4.49 | -3.78 | -3.92 | -5.43 | -5.74 | -11.00 | -12.36 | -19.15 | -23.69 | -10.16 | -11.31 | -28.36 | -39.58 | |
% of Revenue | 85.02 | 84.93 | 84.85 | 84.20 | 83.52 | 79.71 | 75.84 | 71.35 | 66.31 | 63.86 | 60.26 | 60.11 | 59.93 | 54.12 | 44.22 |
SG&A | 185 | 172 | 159 | 168 | 176 | 174 | 172 | 159 | 146 | 134 | 123 | 110 | 98 | 89 | 81 |
Change (%) | -7.11 | -7.66 | 5.38 | 5.11 | -1.10 | -1.12 | -7.73 | -8.38 | -7.82 | -8.48 | -10.16 | -11.31 | -8.80 | -9.65 | |
% of Revenue | 228.24 | 202.27 | 178.58 | 194.09 | 210.60 | 210.19 | 209.78 | 204.61 | 198.81 | 218.31 | 247.03 | 246.43 | 245.68 | 282.43 | 345.07 |
R&D | 27 | 37 | 47 | 46 | 44 | 42 | 39 | 40 | 41 | 39 | 37 | 36 | 35 | 29 | 23 |
Change (%) | 37.19 | 27.11 | -3.04 | -3.13 | -6.04 | -6.43 | 3.21 | 3.11 | -5.02 | -5.28 | -2.33 | -2.39 | -17.08 | -20.60 | |
% of Revenue | 33.21 | 43.47 | 52.83 | 52.83 | 52.83 | 50.10 | 47.32 | 51.62 | 56.44 | 63.86 | 74.79 | 81.11 | 89.00 | 93.03 | 99.90 |
OpEx | 224 | 222 | 220 | 224 | 229 | 227 | 224 | 215 | 205 | 190 | 174 | 157 | 140 | 126 | 112 |
Change (%) | -0.99 | -1.00 | 2.10 | 2.05 | -0.98 | -0.99 | -4.33 | -4.52 | -7.46 | -8.01 | -9.85 | -10.98 | -9.96 | -11.07 | |
% of Revenue | 275.91 | 260.63 | 246.69 | 259.75 | 273.66 | 273.46 | 273.26 | 276.35 | 279.81 | 308.44 | 350.79 | 351.18 | 351.43 | 398.85 | 479.69 |
Operating Income | -143 | -137 | -131 | -138 | -145 | -144 | -142 | -137 | -132 | -128 | -125 | -112 | -100 | -94 | -89 |
Change (%) | -4.29 | -4.48 | 5.59 | 5.30 | -1.03 | -1.04 | -3.71 | -3.85 | -2.69 | -2.69 | -9.81 | -10.96 | -5.71 | -6.05 | |
% of Revenue | -175.91 | -160.63 | -146.69 | -159.75 | -173.66 | -173.46 | -173.26 | -176.35 | -179.81 | -208.44 | -250.79 | -251.18 | -251.43 | -298.85 | -379.69 |
Interest Expense | -4 | -4 | -4 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
Change (%) | -1.01 | -1.02 | -39.95 | -66.52 | 21.71 | 17.84 | 10.05 | 9.13 | -9.66 | -10.70 | -5.68 | -6.02 | -0.85 | -0.86 | |
% of Revenue | -4.75 | -4.49 | -4.25 | -2.63 | -0.91 | -1.12 | -1.33 | -1.54 | -1.79 | -1.92 | -2.12 | -2.22 | -2.35 | -2.94 | -3.94 |
Net Income | -634 | -1,112 | -1,590 | -1,468 | -1,346 | -765 | -183 | -150 | -116 | -113 | -110 | -112 | -113 | -109 | -104 |
Change (%) | 75.47 | 43.01 | -7.68 | -8.32 | -43.19 | -76.04 | -18.39 | -22.53 | -2.52 | -2.58 | 1.59 | 1.57 | -4.18 | -4.36 | |
% of Revenue | -780.36 | -1,306.47 | -1,786.38 | -1,700.92 | -1,609.93 | -922.96 | -223.22 | -192.57 | -158.20 | -183.70 | -221.26 | -249.61 | -284.99 | -344.25 | -445.27 |
Source: Capital IQ